[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583578":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":29,"centralContacts":33,"locations":38,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":10,"overallStatus":73,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,14,17,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Group M",null,"Patients with mucormycosis undergo collection of blood, tissue and BAL fluid samples as well as have their medical records reviewed on study.",[13],"Behavioral: Mucormycosis",{"label":15,"type":10,"description":11,"interventionNames":16},"Group A",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Group B",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"Group C",[13],[24],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"BEHAVIORAL","Mucormycosis","Tell the study team about any symptoms or side effects you have, follow study directions, and come to all study appointments (or contact the study team to reschedule).",[15,18,21,9],[30],{"name":31,"affiliation":5,"role":32},"Dimitrios Kontoyiannis, MD","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":10,"email":37},"CONTACT","(713) 792-0826","dkontoyi@mdanderson.org",[39],{"facility":40,"status":10,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"MD Anderson Cancer Center","Houston","Texas","77030","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-95.36327,29.76328,{"lat":50,"lon":49},[53],{"name":31,"role":35,"phone":54,"phoneExt":10,"email":37},"713-792-0826",{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100583578","mucormycosis-clinical-core-for-the-mucor-advance-p01-project-100583578",false,"NCT06878144","Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project","MD Anderson Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project (Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk Stratification, Diagnosis and Management of the Disease)","Inclusion Criteria:\n\n* Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection.\n* Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care.\n\nExclusion Criteria:\n\n• Patients who are unwilling to undergo routine diagnostic procedures as part of their regular care.","ALL","18 Years","100 Years",{"count":68,"type":69},300,"ESTIMATED","OBSERVATIONAL","To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.",[26],"NOT_YET_RECRUITING","2025-09-05",{"date":76,"type":77},"2025-09-08","ACTUAL",{"date":79,"type":69},"2025-09-30",{"date":81,"type":69},"2032-12-31",{"name":5,"class":6},1]